Category: Hepatitis
Global Hepatitis
-
Global Prophylactic Hepatitis B Virus Vaccines Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Prophylactic Hepatitis B Virus Vaccines is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
-
Infectious Vaccines Market Size, Trends, Analysis, and Outlook By Type (Inactivated Vaccines, Live Attenuated Vaccines, DNA and Recombinant Vector Vaccines, Others), By Disease(Typhoid, Tuberculosis, Tetanus and Diphtheria, Influenza, Hepatitis, Polio, Others), By Distribution Channel (Hospitals, Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030 The global Infectious Vaccines market size is poised to register 6.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Specialty Generics Market Size, Trends, Analysis, and Outlook By Type (Injectables, Oral drugs, Others), By Application (Oncology, Inflammatory conditions, Multiple sclerosis, Hepatitis C, Others), By End-user (Specialty pharmacy, Retail pharmacy, Hospital pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Specialty Generics market size is poised to register 11.48% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the ... Read More
-
Antiviral Drugs Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Class, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030
... Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antiviral Drugs market size is poised to register 4.55% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Point of Care Diagnostics Market by Product (Glucose, HIV, Hep C, HPV, Hematology, Pregnancy), Platform (Microfluidic, Dipstick, RT-PCR, INAAT), Sample(Blood, Urine), Purchase (OTC, Rx), End User (Pharmacy, Hospitals, Home Care) - Global Forecast to 2028
... The point of care diagnostics market is epected to reach USD 77.8 billion by 2028 from an estimated USD 49.7 billion at a CAGR of 9.4% during the forecast period (2023–2028).The gobal rising burden of ... Read More
-
The 2025-2030 World Outlook for Hepatitis Diagnostics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Hepatitis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Hepatitis C Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Hepatitis B Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Hepatitis C Therapies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Hepatitis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Hepatitis Test Solution-Diagnosis
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Hepatitis B Diagnostic Tests
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Hepatitis B Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Viral Infection Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Anti-Hepatitis Drugs and Vaccines
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Hepatitis C Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Mono Hepatitis B Vaccines
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Hepatitis C Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The World Market for Vaccines, 2024
... adoption of effective vaccines has led to the near-elimination of many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Thanks to public vaccination programs, vaccine-preventable diseases and related ... Read More
-
Lateral Flow Assay Market by Product (Kit, Readers), Application (STI, Covid-19, Hep, TB, Cardiac marker, Pregnancy; Drug abuse, Vet Diaganostic, Food), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User - Global Forecast to 2029
... The lateral flow assays market is valued at an estimated USD 10.8 billion in 2023 and is projected treach USD 16.8 billion by 2029, at a CAGR of 7.6% during the forecast period. The rising ... Read More
-
Global Hepatitis Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029
... to reach USD 5.91 billion by 2029, growing at a CAGR of 5.67% during the forecast period (2024-2029). The impact of COVID-19 in its initial phase was adverse owing to cancellations of diagnostic procedures worldwide. ... Read More
-
Global Human Hepatitis B Immunoglobulin (HBIG) Market Growth 2024-2030
... demand in downstream market, the Human Hepatitis B Immunoglobulin (HBIG) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Hepatitis B Vaccines Market Growth 2025-2031
... to 2031. Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those ... Read More
Research Assistance
